Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Anatara Lifesciences Ltd ( (AU:ANR) ) has provided an update.
Anatara Lifesciences Limited has announced a change in the director’s interest notice concerning Dr. David Brookes. The company disclosed that Dr. Brookes has disposed of 932,143 unlisted options, with no new securities acquired. This change reflects adjustments in Dr. Brookes’ holdings, which include both direct and indirect interests through various trusts and superfunds. The announcement is part of the company’s compliance with ASX listing rules, ensuring transparency in the director’s financial interests.
More about Anatara Lifesciences Ltd
Average Trading Volume: 1,382,602
Technical Sentiment Signal: Sell
Current Market Cap: A$4.08M
For a thorough assessment of ANR stock, go to TipRanks’ Stock Analysis page.